It never ceases to amaze me that I work with a fantastic group of people who helped me put this together in three hours. Thanks @wandering-gu.bsky.social for answering questions about former President Joseph Biden’s diagnosis: michmed.org/WXXej.
It never ceases to amaze me that I work with a fantastic group of people who helped me put this together in three hours. Thanks @wandering-gu.bsky.social for answering questions about former President Joseph Biden’s diagnosis: michmed.org/WXXej.
Thank you!!
Great working with Patrick Squires and the Merck team on this MIBC RWA #gu25 @ascocancer.bsky.social
Sheesh! #GU25 @ascocancer.bsky.social
We're hiring a PhD clinical psychologist or social worker! Looking for an energetic, passionate faculty colleague whose role would be to lead the clinical and research component of our survivorship program. Sexual health certification is desired. careers.umich.edu/job_detail/2...
Any recent data on screening rates?
We’ve decided on the AUA Book
club pick for 2025!
James by @percivaleverett.bsky.social
Info on time & meeting place coming soon. Support your local bookstore. 📚
See you in Las Vegas!
In Memory of Dr Felix Feng, our beloved friend and a giant in prostate cancer @ericsmall.bsky.social @ucsfcancer.bsky.social
www.sciencedirect.com/science/arti...
So excited about this work, led by UMich Pathologist Cathryn Lapedis. We're accustomed to providing patients with reports that are uninterpretable to them, then having a subsequent decoding discussion. What happens when we make the reports understandable the first time around?@bzikmund.bsky.social
Fascinating!
“Most study participants (44-61%) could not extract basic information—including whether they have cancer—from standard prostate cancer pathology reports but [in contrast] 93% were able to understand this diagnostic information from” patient-centered pathology reports
I've published literally hundreds of studies, but this one will always be special. I'm so proud to have helped Dr. Cathryn Lapedis show so convincingly how BAD current prostate biopsy pathology reports are compared to a simple patient-centered design. PLUS: my first JAMA article ever!
Thrilled to announce that my dear friend and colleague, Jay Simhan, MD, FACS, has been named Chair of Urology at Temple University Hospital!
I’m thrilled to partner as two departments under the Fox Chase-Temple Urologic Institute to elevate our already world-class program to even greater heights!
😀 🏝️
Merry Christmas and Happy Hanukkah!
So fun to go on Backtable Urology and highlight the work of the AUA/ASTRO/SUO prostate cancer salvage therapy guidelines committee. open.spotify.com/episode/7EwC...
Hey I was there for Coffey-Holden 2014! (Although the pic from my run looks different…)
Pics are unreal. Where?
Found this guy in beautiful Linthicum recently @dr-coops.bsky.social
Felix Feng, MD
It is with great sadness that we mourn our cherished friend and colleague Felix Feng, MD. Felix was a distinguished physician-scientist and beloved at @ucsfhealth.bsky.social. His vision, dedication, and commitment inspired colleagues, peers everywhere, and patients. cancer.ucsf.edu/in-memoriam-...
🎯
It’s great data, but the NPV isn’t necessarily all that meaningful given that only a handful those patients underwent a biopsy. Eg could have just performed a biopsy on none of those patients and get an NPV of 100%.
You guys were a 🔥🔥 team
Huge kudos to the NCCN for officially incorporating prostate cancer into the Genetic/Familial High-Risk Assessment Guidelines. We've come a long way!
You guys are 🔥 🔥 🔥
So proud that my mom--after an amazing career in journalism--is still able to write stuff like this 😍
www.seattletimes.com/opinion/my-v... @seattletimes.bsky.social @pancan.bsky.social
Happy to share our GWAS of hydrocele. We found that key developmental genes are associated with this common adult phenotype 🧪
#urology #SurgSky
www.nature.com/articles/s41...
Josh is by far one of the greatest minds in bladder cancer. When he speaks you should listen. Changing the game.
Huge need to get away from single arm trials in local therapy for cancer, in general. Often hard to get funding. But let’s be creative. And most importantly, let’s (physicians) not be the barrier to learning.
Optimizing #cancer treatment should not be a guessing game. #science for the win🥇